Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.

Asamoto, H; Kawahara, M; Iwami, F; Kuba, M; Furuse, K; Tamura, T; Saijo, N; Shimoyama, M

Asamoto, H; Kawahara, M; Iwami, F; Kuba, M; Furuse, K; Tamura, T; Saijo, N; Shimoyama, M.

Affiliation

Asamoto H; Department of Respiratory Diseases, Kyoto National Hospital, Japan.

Jpn J Clin Oncol ; 28(12): 745-8, 1998 Dec.

Article in En | MEDLINE | ID: mdl-9879292

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Small Cell/drug therapy; Lung Neoplasms/drug therapy; Administration, Oral; Adult; Aged; Alopecia/chemically induced; Anemia/chemically induced; Anorexia/chemically induced; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carcinoma, Small Cell/mortality; Cisplatin/administration & dosage; Cisplatin/adverse effects; Drug Administration Schedule; Etoposide/administration & dosage; Etoposide/adverse effects; Female; Humans; Infusions, Intravenous; Leukopenia/chemically induced; Lung Neoplasms/mortality; Male; Middle Aged; Nausea/chemically induced; Thrombocytopenia/chemically induced; Vomiting/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Small Cell / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 1998 Document type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links